Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome
Abstract Hand-foot syndrome (HFS), also known as palmar-plantar erythrodysesthesia (PPE), is a major side effect of capecitabine. Although the pathogenesis of HFS remains unknown, some studies suggested a potential involvement of inflammation in its pathogenesis. Proton pump inhibitors (PPIs) have b...
Guardado en:
Autores principales: | Shiori Hiromoto, Takehiro Kawashiri, Natsumi Yamanaka, Daisuke Kobayashi, Keisuke Mine, Mizuki Inoue, Mayako Uchida, Takao Shimazoe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/edd08d6edf7b40e8b4966dce32425657 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS)
por: Takehiro Kawashiri, et al.
Publicado: (2021) -
The Proton Pump Inhibitor Omeprazole Does Not Promote <named-content content-type="genus-species">Clostridioides difficile</named-content> Colonization in a Murine Model
por: Sarah Tomkovich, et al.
Publicado: (2019) -
Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Wei Liu, et al.
Publicado: (2019) -
Proton pumping accompanies calcification in foraminifera
por: Takashi Toyofuku, et al.
Publicado: (2017) -
Gastric proton pump with two occluded K+ engineered with sodium pump-mimetic mutations
por: Kazuhiro Abe, et al.
Publicado: (2021)